Skandinaviska Enskilda Banken (SEB)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,100
| Closed | -$563K | – | 1212 |
|
|
2020
Q4 | $563K | Sell |
12,100
-5,200
| -30% | -$242K | ﹤0.01% | 897 |
|
|
2020
Q3 | $735K | Sell |
17,300
-17,100
| -50% | -$727K | 0.01% | 782 |
|
|
2020
Q2 | $1.65M | Buy |
34,400
+900
| +3% | +$43.2K | 0.01% | 620 |
|
|
2020
Q1 | $1.54M | Sell |
33,500
-800
| -2% | -$36.8K | 0.02% | 542 |
|
|
2019
Q4 | $2.06M | Buy |
34,300
+300
| +0.9% | +$18K | 0.02% | 557 |
|
|
2019
Q3 | $1.92M | Sell |
34,000
-5,500
| -14% | -$311K | 0.02% | 557 |
|
|
2019
Q2 | $2.2M | Sell |
39,500
-16,500
| -29% | -$919K | 0.02% | 484 |
|
|
2019
Q1 | $2.83M | Buy |
56,000
+3,700
| +7% | +$187K | 0.03% | 392 |
|
|
2018
Q4 | $2.11M | Buy |
52,300
+7,700
| +17% | +$310K | 0.02% | 462 |
|
|
2018
Q3 | $3.09M | Buy |
+44,600
| New | +$3.09M | 0.02% | 390 |
|